Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • Does the presence of NAFLD inf...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
Does the presence of NAFLD influence prescribing behaviour in Type 2 diabetes?

Does the presence of NAFLD influence prescribing behaviour in Type 2 diabetes?

書目詳細資料
Main Authors: Whyte, MB, McGovern, A, Hinton, W, Arrowsmith, B, de Lusignan, S
格式: Conference item
語言:English
出版: Wiley 2017
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

相似書籍

  • Disparities in the monitoring and complication screening of people with Type 2 diabetes
    由: Hinton, W, et al.
    出版: (2017)
  • Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
    由: Shah, S, et al.
    出版: (2018)
  • Is diabetes really a risk factor for acute eye infection?
    由: Ansari, AS, et al.
    出版: (2017)
  • Ethnic disparities in medication persistence in Type 2 diabetes: non-whites have reduced persistence
    由: McGovern, AP, et al.
    出版: (2016)
  • Ethnic and socioeconomic disparities in type 2 diabetes care: A trend analysis
    由: Hinton, W, et al.
    出版: (2017)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題